FacultyFaculty/Author Profile

Peter D. Lyons

Freshfields Bruckhaus Deringer

New York, NY, USA


Widely recognized as one of the most prominent M&A lawyers in the United States, Peter represents leading US and global companies in acquisitions and sales of public and private companies, asset acquisition and disposition transactions, and joint ventures. Previously, Peter was a partner with Shearman & Sterling LLP.

Peter has been recognized and recommended as an M&A practitioner by Chambers Global, Chambers USA, The Legal 500 US, and IFLR1000. He has written and spoken extensively on M&A and corporate law.

Peter’s experience includes advising:

  • Zillow, Inc. on its $3.5bn acquisition of Trulia, Inc. in a stock­for­stock transaction;
  • Sun Pharmaceutical Industries in its pending acquisition of Ranbaxy and its acquisition of the publicly traded shares of Caraco Pharmaceutical Laboratories, Ltd. and control of Taro Pharmaceutical Industries Ltd.;
  • Textron Inc. on its $1.4bn acquisition of Beechcraft and the combination with its Cessna business to form Textron Aviation;
  • ArcelorMittal in its joint acquisition (with Nippon Steel & Sumitomo Metal Corporation) of ThyssenKrupp Steel USA;
  • Nokia Corporation in the formation of Nokia Siemens Networks and its acquisition of Siemens’ interest in Nokia Siemens Networks and the acquisition of Navteq Corporation;
  • the special committee of the board of directors of Sprint Nextel Corporation on the $21.6bn acquisiton of 78% of Sprint Nextel Corporation by Softbank Corp;
  • the independent directors of Psychiatric Solutions, Inc. in its acquisition by Universal Health Services, Inc.;
  • Gambro AG in the sale of the issued and outstanding stock of CaridianBCT Holding Corp. to Terumo Corporation; Gambro AB in its acquisitions of Cobe Laboratories, Inc. and Vivra Incorporated; its investments in, and subsequent acquisition of, Ren­Corporation USA; its investment in Hemasure, Inc.; its divestiture of Gambro Healthcare, Inc. to DaVita Inc.; its distribution agreement with Baxter Healthcare Corporation; and its independent directors in the acquisition of Gambro by Indap AB;
  • JetBlue Airways Corporation on the $400m sale of LiveTV to Thales SA and on the $300m sale of 19% of its common stock to Lufthansa;
  • BASF AG in its acquisitions of Engelhard, Micro Flo Co., Chemdal, Cyanamid Corporation and the Latex Division of Polysar Limited; the swap of its container coatings business for the surfactants business of PPG Industries; the swap of its fibers business for Honeywell, Inc.’s plastics business; and the sale of its Fritzsche Dodge & Cie flavors and fragrance business;
  • Boston Scientific Corporation in its acquisitions of Guidant Corporation, Scimed Life Systems, Inc., Cardiovascular Imaging Services, Inc., Meadox Medicals, Inc., Mintec, Inc., the Schneider division of Pfizer Inc., Target Therapeutics, Inc., Interventional Technologies Inc. and Quanam Medical Corporation; the sale of Guidant’s vascular intervention business to Abbott Laboratories; and its equity investment in Biophan Technologies, Inc.; and
  • Siemens AG and its subsidiaries in the sale of its worldwide pacemaker business to St. Jude Medical and Unisphere, Inc. to Juniper Networks, Inc.; and the acquisitions of UGS Corporation, Efficient Networks, Pyramid Technologies, and Sylvania’s North American lighting business from GTE; and the water systems and services division of United States Filter Corporation, a subsidiary of Veolia Environnement S.A.

Qualifications and education

Peter received his JD from Georgetown University Law Center and his BA from the University of Virginia. He is admitted to practice in New York and California.

 

Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.